C Financing Cash Flow

Citigroup · Financing Cash Flow

C logo

C Financing Cash Flow

Latest reported$228.13B
C TTM Cash from Financing ($1.42B → $228.13B)
High-resolution chart · PNG

C financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Citigroup Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
228,128,000,000
124,304,000,000
238,031,000,000
165,444,000,000
160,150,000,000
134,321,000,000
-38,304,000,000
54,735,000,000
-4,621,000,000
-2,728,000,000
687,000,000
21,149,000,000
66,237,000,000
95,175,000,000
137,763,000,000
20,974,000,000
43,103,000,000
42,371,000,000
17,272,000,000
65,429,000,000
50,486,000,000
75,492,000,000
233,595,000,000
197,814,000,000
222,344,000,000
194,754,000,000
42,933,000,000
79,703,000,000
43,541,000,000
36,702,000,000
44,528,000,000
40,893,000,000
57,217,000,000
95,079,000,000
66,854,000,000
54,284,000,000
49,418,000,000
8,552,000,000
28,292,000,000
15,142,000,000
-8,637,000,000
-6,043,000,000
-64,773,000,000
-91,559,000,000
-99,384,000,000
-103,366,000,000
-98,074,000,000
-26,646,000,000
7,858,000,000
17,796,000,000
30,896,000,000
-23,759,000,000
-34,706,000,000
-53,152,000,000
-25,364,000,000
12,691,000,000
-24,398,000,000
-45,810,000,000
-56,646,000,000
-76,576,000,000
-11,667,000,000
-12,459,000,000
-77,428,000,000
-47,266,000,000
-70,598,000,000
-4,860,000,000
13,006,000,000
55,811,000,000
4,203,000,000
-60,214,000,000
-24,537,000,000
-108,105,000,000
19,082,000,000
108,341,000,000
144,494,000,000
274,214,000,000
230,842,000,000
214,213,000,000
206,430,000,000
128,410,000,000
92,760,000,000
57,211,000,000
33,174,000,000
41,006,000,000
49,125,000,000
53,264,000,000
83,311,000,000
74,226,000,000
93,242,000,000
86,842,000,000
64,405,000,000
67,057,000,000
34,809,000,000
37,528,000,000
27,950,000,000
1,978,000,000
14,858,000,000
5,984,000,000
15,752,000,000
40,303,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.